Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0882420160900030258
Korean Journal of Medicine
2016 Volume.90 No. 3 p.258 ~ p.261
Successful Treatment of Relapsed Acquired Amegakaryocytic Thrombocytopenia with Repeat Cyclosporine
¹è¼ö¾ß:Bae Soo-Ya
ÇÑÅÂÈñ:Han Tae-Hee/¼Õº´¼®:Sohn Byeong-Seok/¿ÀÇöÈ£:Oh Hyun-Ho/ÃÖ¼ºÁø:Choi Seong-Jin/¹Ú¹®:Park Moon/À¯¿µÁø:Yuh Young-Jin
Abstract
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments have been tried, with varying outcomes. In some case reports, cyclosporine and anti-thymocyte globulin have had good clinical results in the treat of AAMT. There are few reports on the treatment of relapsed AAMT with cyclosporine. We report a patient with relapsed AAMT who was treated successfully with an additional course of cyclosporine. The initial remission was achieved with cyclosporine 4 years earlier and a second remission was induced by cyclosporine. Cyclosporine may be effective for relapsed AAMT that previously responded to cyclosporine.
KEYWORD
Acquired amegakaryocytic thrombocytopenia, Cyclosporine
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø